THE PROSTATE CANCER FOUNDATION named 24 Young Investigator Award winners. Members of the Class of 2016 were selected from a pool of 128 applicants from 77 institutions across 15 countries. Successful proposals included the use of genomics to predict prognosis and personalize treatments, as well as immunological approaches. The projects predominantly concentrated on treatment-resistant prostate...
How’s this for a paradox: The better cancer centers become at keeping patients alive, the more expensive cancer care becomes. This brutal tradeoff hits harder in rural areas, where the cancer burden is higher and the investigator and clinical trial representation is lower.
